PEOPLE - AngioTech Pharmaceuticals makes appointment:
This article was originally published in Clinica
Executive Summary
Canadian company AngioTech Pharmaceuticals has elected John McDermott, president of vascular products company IMPRA, to its board of directors. AngioTech develops medical device coatings and treatments for chronic inflammatory diseases.